| STAT1 |
Foam-cell formation, atherosclerotic lesion development, MC apoptosis, VSMCs de-differentiation and proliferation, neointimal hyperplasia, elevated expression of chemokines, promotion of oxidative stress and tissue injury. |
[74, 87–91] |
| STAT2 |
Regulation of type I IFN signaling and gene expression. |
[92] |
| STAT3 |
VSMCs de-differentiation, lesion formation, recruitment of inflammatory cells to the vessel wall. |
[93, 94] |
| IRF1 |
Protection against neointima formation, iNOS activation in response to stress conditions, increased ventricular dilation and fibrosis, acceleration of vascular remodeling, exacerbation of ischaemic stroke. |
[97–100] |
| IRF8 |
Cells proliferation, neointima and lesion formation, association of IRF8 gene polymorphism with coronary heart disease in SLE, elevated expression in response to mechanical injury of the artery, VSMCs phenotypic switching, induction of M1 phenotype in MC, negative regulator of pathological cardiac hypertrophy. |
[100–102, 105] |